At O-Ray, our mission is to develop novel therapies to facilitate improved care and optimally, the cure for serious ear disease. We are known for our proprietary drug delivery technologies and pioneering approach to hearing loss.
Our objective is to develop therapies from proof of concept to regulatory approval to help patients with hearing related disorders.
At O-Ray Pharma, we are able to leverage more than 30 years of experience from our scientific team in extended release delivery systems in a basic and applied research environment. Our early success in securing NIH funding for much of this work is indicative of the level of expertise and the advanced state of O-Ray’s technology.